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ABSTRACT To assess the significance of the NH2-terminus of actin for cross-bridge action in muscle, skinned fibers of
rabbit psoas muscle were equilibrated with Fab fragments of antibodies directed against the first seven N-terminal residues
of actin. With the antibody fragment, active force is more inhibited than relaxed fiber stiffness, or stiffness in rigor or in the
presence of magnesium pyrophosphate. Inhibition of stiffness in rigor or with magnesium pyrophosphate does not necessarily
indicate involvement of the NH2-terminus of actin in strong cross-bridge binding to actin but may simply result from the large
size of the Fab. At high Fab concentrations, active force is essentially abolished, whereas stiffness is still detectible under all
conditions. Thus, complete inhibition of active force apparently is not due to interference with cross-bridge binding to actin
but may result from the Fab-mimicking inhibition of the thin filament by Troponin-I binding to the NH2-terminus of actin at low
Ca2 . However, although Troponin-l is released from the NH2-terminus at high Ca2 , the Fab is not, thus disallowing force
generation upon increase in Ca2+. These data are consistent with involvement of the NH2-terminus of actin in both weak
cross-bridge binding to actin and Ca2+ regulation of the thin filament.
INTRODUCTION
It is believed that during muscle contraction myosin heads
cycle between two main groups of states as ATP is hydro-
lyzed. The states of the first group are characterized by the
low affinity of myosin heads for actin and their limited
ability to activate thin filaments. They are commonly
termed the "weakly binding" cross-bridge states. Myosin
cross-bridges in the second group of states, commonly
termed the "strongly binding" states, have much higher
actin affinity under comparable experimental conditions
and, in contrast to the weakly binding states, can activate
thin filaments. It has been hypothesized that the transition
from the weakly bound to the strongly bound cross-bridge
configuration is a major step in force generation in muscle
(Eisenberg and Greene, 1980; Eisenberg and Hill, 1985;
Brenner, 1990; Brenner et al., 1995; Kraft et al., 1995a).
Several lines of experimental evidence indicate structural
differences between the weakly and strongly bound acto-
myosin complexes (Craig et al., 1985; Applegate and
Flicker, 1987; Yu and Brenner, 1989; Barnett and Thomas,
1989; Duong and Reisler, 1989; Brenner and Yu, 1993a;
Berger and Thomas, 1994; Thomas et al., 1995; Walker et
al., 1994, 1995; however, also see Pollard et al., 1993),
suggesting that different sites on actin and myosin may be
involved in the two types of interaction. This idea is incor-
porated into the structural model of actomyosin complexes
(Rayment et al., 1993), which predicts mainly electrostatic
interactions between myosin and actin in the weakly bound
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states (in the presence of ATP), and the combined electro-
static and hydrophobic interactions for the strongly bound
complexes. On the basis of biochemical data (Reisler, 1993)
and structural considerations, the electrostatic interactions
are proposed to involve primarily the basic residues in loop
626-647 on the myosin head and the cluster of acidic
residues in the N-terminal segment of actin and its 21-29
and 92-103 loops (Rayment et al., 1993).
The binding of the first 10 N-terminal residues of actin to
myosin was originally documented and analyzed in chemical
cross-linking studies (Mornet et al., 1981; Sutoh, 1991;
Yamamoto, 1991). From more recent work it seems that this
binding is particularly important in the presence of ATP
(Chaussepied and Morales, 1989; DasGupta and Reisler, 1989;
Bertrand et al., 1989) in the weakly bound actomyosin states.
However, not only the myosin head but also the regulatory
proteins Troponin-I (TnI) (Grabarek and Gergely, 1987; Le-
vine et al., 1988) and caldesmon (Patchell et al., 1989; Bartegi
et al., 1990; Levine et al., 1990; Adams et al., 1990) were
proposed to interact with the N-terminal residues of actin.
Further clarification of these binding interactions was
obtained from the work with N-terminal actin mutants (Su-
toh et al., 1991; Cook et al., 1993; Crosbie et al., 1994).
These studies revealed that the electrostatic interactions of
myosin and caldesmon with the N-terminus of actin are
functionally important even if they contribute little to the
overall binding of these proteins. Similar conclusions were
also reached from previous experiments with peptide anti-
bodies. It was shown in these studies that Fab(1-7), anti-
body fragments against the first seven N-terminal residues
on actin, inhibited the binding of myosin subfragment-1
(S-1) to actin in both the presence and absence of nucle-
otides (DasGupta and Reisler, 1991, 1992). In the presence
of ATP, acto-S-1 ATPase was inhibited by Fab(1-7) to a
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larger extent than expected from the inhibition of S-I bind-
ing to actin. It was concluded that Fab(1-7) could inhibit
both the binding of S-i to actin in the presence of ATP and
a catalytic step in the ATP hydrolysis cycle (DasGupta and
Reisler, 1992).
In this study, we examined the effect of Fab(l-7) anti-
body fragments on cross-bridge binding to actin and force
generation in skinned rabbit psoas muscle fibers. A prelim-
inary account of this work was presented earlier (Brenner et
al., 1993).
MATERIALS AND METHODS
Fiber preparation
Skinned fibers of rabbit psoas muscle were isolated and chemically skinned
with Triton X-100 as previously described (Brenner, 1983; Brenner and
Yu, 1993b; Yu and Brenner, 1989) but with the recent modification of
adding several protease inhibitors (for details see Kraft et al., 1995a).
Single fibers were isolated as previously described (Yu and Brenner, 1989)
but within a few hours after dissection of fiber bundles from the rabbit.
Isolated single fibers were kept for up to 5 days without any detectable loss
of sarcomeric proteins but with the advantage of much improved diffusion
of substrate and products.
Solutions
All solutions were adjusted to pH 7.0 at the experimental temperature
(5°C). Chemicals were obtained from Sigma Chemie (Miinchen, Germa-
ny), except when noted otherwise. Skinning solution contained (in mM):
5.0 KH2PO4; 3.0 magnesium acetate; 5.0 EGTA; 1.0 Na2ATP (Merck, St.
Louis, MO); 50 sodium creatine phosphate; 5.0 NaN3; 10 glutathione; 2.0
DTT, 0.1 AEBSF (Calbiochem, La Jolla, CA); 0.01 each of leupeptin,
antipain, E64, and pepstatin; and 1 ,ug/ml aprotinin (cf. Kraft et al., 1995a).
Standard experimental solutions contained (in mM): 10 imidazole, 2.0
MgCl2, 1.0 MgATP, and 1.0-3.0 EGTA (or CaEGTA). Preactivation and
activation solutions contained an additional 10 mM caffeine and 500 U/ml
(Sigma units) of creatine kinase; ionic strength was adjusted by adding the
appropriate amount of sodium creatine phosphate, assuming a contribution
to ionic strength of 3 mM/mM of sodium creatine phosphate. Rigor solution
contained (in mM): 10 imidazole, 2.5 EGTA, and 2.5 EDTA. Magnesium
pyrophosphate (MgPPi) solution contained (in mM): 10 imidazole, 4.0 MgPPi,
2.0 MgCl2, 1.0 CaEGTA, and 0.2 Ap5A. MgATPyS-solution contained (in
mM): 10 imidazole, 10 MgATPyS, 2.0 MgCl2, 3.0 EGTA, 200 glucose, 0.5
U/ml hexokinase, and 0.2 Ap5A. ATPyS was purified as previously described
(Kraft et al., 1992). For all solutions except preactivating and activating
solution, ionic strength was adjusted by adding appropriate amounts of potas-
sium propionate.
Fab fragments
Affinity purified Fab(1-7) antibody fragments were prepared as described
previously (Miller et al., 1987). The rhodamine labeling of the antibody
fragment was carried out in 0.1 MNaCO3, pH 9.0, at 50:1 molar ratio of
tetramethyl rhodamineisothiocyanate (TRITC) to Fab(1-7) (1.0 mg/ml).
The reaction was allowed to proceed for 8 h in the dark at 4°C. The labeled
Fab was separated from excess TRITC on a Sephadex G-50 spin column
and by subsequent dialysis versus PBS. The labeling stoichiometry (0.2
TRITC/Fab) was determined spectrophotometrically.
Mechanical apparatus and x-ray diffraction
Equipment for recording of force, fiber stiffness, and equatorial x-ray diffrac-
tion patterns was described in detail elsewhere (Brenner, 1980; Brenner et al.,
1984; Brenner and Eisenberg, 1986).
Stiffness measurements
Fiber stiffness was measured by imposing ramp-shaped stretches on the
skinned fibers. Speed of stretch was between 103- 104 (nm/half-
sarcomere)s-1 unless stated otherwise. Stiffness (chord stiffness) was
defined as the ratio of force increment over that length increment when
amplitude of stretch had reached 2 nm/half-sarcomere.
Confocal microscopy
Equilibration of skinned fibers with rhodamine-labeled Fab (1-7) was fol-
lowed by confocal microscopy to characterize the labeling pattern within the
sarcomere and to estimate the time required for reaching equilibrium of the
antibody across the fiber.
The system for confocal microscopy was described previously (Kraft et
al., 1995b) and consisted of a fluorescence microscope (Axiophot, Zeiss,
Oberkochen, Germany), a confocal scanner (MRC-600, Biorad, Zurich,
Switzerland) and a work station (Silicon Graphics Personal Iris 4D/25).
The system was equipped with an argon/krypton mixed gas laser and
allowed simultaneous recording of both rhodamine and fluorescein signals.
The images were recorded using a Zeiss Planapochromat 40X, N.A. 1.0,
oil immersion objective. Image processing was carried out on the Silicon
Graphics work station using "Imaris" (Messerli et al., 1993), a 3D-mul-
tichannel image-processing software specialized for confocal microscopic
images (Bitplane AG, Technopark, Zurich, Switzerland).
To follow equilibration by confocal microscopy, fibers were mounted in
a shallow slot-shaped chamber built on a microscope slide and closed with
a coverslip (cf. Kraft et al., 1995b).
Equilibration of skinned muscle fibers
with Fab(1-7)
Skinned fibers were equilibrated with Fab(l-7) in a relaxing solution. The
ionic strength of the relaxing solution was set at 50 mM so that potential
effects of Fab(1-7) on relaxed fiber stiffness could be monitored contin-
uously. The incubation medium was composed of standard relaxing buffer
to which 25 mM glutathione and protease inhibitors were added as de-
scribed for the skinning solution. Without these additional components,
mechanical stability of the fibers decayed, presumably because of protease
activity contaminating the Fab(1-7) preparation, such that after several
hours of incubation, fibers could no longer sustain transfer through an
air-solution interface.
RESULTS
Time course of inhibition of active force and
relaxed fiber stiffness
To examine the equilibration of skinned rabbit psoas fibers
with Fab(I-7) molecules, we first followed the effect of
Fab(I-7) on relaxed fiber stiffness and active force during
several hours of incubation. A representative example of such
measurements is shown in Fig. 1. After between 8 and 10 h of
incubation, the active force, both at high (170 mM) and low
(50 mM) ionic strength, was essentially fully abolished,
whereas relaxed fiber stiffness was reduced by only -40-
50%. The inhibition of relaxed fiber stiffness was also virtually
unchanged by ionic strength conditions (between 50 and 170
mM), suggesting that the effect of Fab(i-7) was not signifi-
cantly altered when actin affinity of weakly bound cross-
bridges was increased by lowering the ionic strength.
When protease inhibitors were not included in the incu-
bation medium, relaxed fiber stiffness continued to decrease
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FIGURE 1 Inhibition of active force and relaxed fiber
stiffness by 0.05 mg/ml Fab(1-7). Time course of inhi-
bition of relaxed fiber stiffness at ,u = 50 mM (@) and
of active force at ,u = 50 mM (L]) and 170 mM (*).
Note that active force is almost completely inhibited
(<2-3%), whereas relaxed fiber stiffness is reduced to
only -50-60%.
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with time of incubation to values lower than those shown in
Fig. 1. This decrease, however, was accompanied by a
decay in fiber stability such that they eventually could not
sustain the transfer through an air-solution interface. In the
presence of protease inhibitors, relaxed fiber stiffness
reached a steady level after between 10 and 12 h, suggesting
that - 12 h of incubation were required for the equilibration
of single skinned fibers with Fab(1-7).
To probe whether the more pronounced inhibition of
active force could result from a decrease in Ca2+-sensitivity
of the contractile system in the presence of Fab(1-7), active
force measurements were also carried out at increased
Ca2+-concentrations. An increase of free Ca2+-concentra-
tion, at least up to 2 mM, did not result in a detectable
recovery of active force (data not shown).
Equilibration of muscle fibers with Fab(1-7) and
resulting labeling pattern within the sarcomere
Time course
To better establish the time course of equilibration of skinned
muscle fibers with Fab(1-7), and to identify the structural
element(s) that bind the antibody fragment, the equilibration of
skinned muscle fibers with rhodamine-labeled Fab(1-7) (0.05
mg/ml) was followed by confocal microscopy. As shown in
Fig. 2, after --12 h of incubation the fluorescence reached a
uniform intensity all the way to the core of the fiber. In contrast
to that, only superficial labeling can be seen after 40 min of
incubation with Fab(1-7). Fig. 2, B and C, shows homogenous
fluorescence within each sarcomere, except for the H-zone in
which fluorescence intensity remains low. This pattern is con-
sistent with homogenous and selective labeling along the
whole length of actin filaments.
Concentration dependence
After 12 h of incubation at 0.05 mg/ml Fab(I-7), the re-
laxed fiber stiffness was inhibited by 42 ± 15% (mean ±
0 S
0
0
. I 0
0
0
0
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SD, n = 6). At this antibody concentration the active force
was essentially abolished, at both high and low ionic
strength (Fig. 1). At higher concentrations of Fab(I-7), the
relaxed fiber stiffness was inhibited further to -25% of the
original value. However, inhibition of relaxed fiber stiffness
may not have reached saturation even at the highest
Fab(1-7) concentration (0.5 mg/ml) studied.
Structural examination of fibers incubated with
Fab(1-7)
We previously observed massive structural disorder (e.g.,
due to actin filament bundling) that resulted in complete
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FIGURE 2 Equilibration of skinned fibers with Rhodamine-labeled Fab(1-
7). The incubations of fibers with 0.05 mg/ml rhodamine-labeled Fab(l-7)
were carried out in relaxing solution (,u = 50 mM) for40 min (A) and 13 h (B).
Note that in B the homogeneously labeled areas of the sarcomeres correspond
to actin filaments; i.e., the nonfluorescently labeled gaps represent the H-zone.
This is more clearly identified in C where the sarcomeric M-line was labeled
with an antibody directed against the M-line-specific protein myomesin (Ep-
penberger et al., 1981; Grove et al., 1984). This antibody, in turn, was stained
with a secondary FITC-labeled rabbit anti-goat antibody (Cappel Dynatech,
Zurich, Switzerland). Before incubation with the rhodamine-labeled Fab(1-7),
the fiber was preincubated for 4 h with both the antimyomesin antibody (0.02
mg/ml) and the FITC-labeled rabbit anti-goat antibody (diluted 1:100). Even
after 4 h of incubation no equilibration was reached for staining the M-line-
specific protein myomesin, i.e., only the superficial layers of the fiber were
stained. Approximately 30 min after addition of 0.05 mg/ml rhodamine-
labeled Fab(1-7) to the incubation medium (relaxing solution, ,u = 50 mM),
both rhodamine and fluorescein signals were recorded simultaneously. The
core region of the fiber is near the bottom edge of the figure.
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loss of even the strongest equatorial reflections 1,1, and 1,0,
when single fibers were equilibrated with some S-i-derived
peptides at concentrations (micromolar) that affected active
force and relaxed fiber stiffness (Brenner, unpublished
data). To rule out the possibility that such massive structural
disorder was the main cause for the observed inhibition of
active force and relaxed fiber stiffness in the presence of
Fab(I-7), equatorial diffraction patterns of fibers were re-
corded in the presence and absence of antibodies (Fig. 3).
We found a decrease in the intensity of the 1.0 reflection
by -18%, associated with a corresponding increase in the
1.1 reflection (-22%) upon addition of Fab(I-7). This is
consistent with binding of proteins or protein fragments to
actin with some inhibition of cross-bridge attachment. The
increase in background counts by 12% reflects an increase
in diffuse scatter within the fibers (nonmuscle background
is subtracted), which is possibly due to the presence of
additional mass in the beam (e.g., presence of the Fab) or to
some small amount of structural disorder or both. Because
the total integrated intensities within the reflections is also
increased (by 8%), the main factor seems to be increase in
mass rather than structural disorder. Thus, the diffraction
patterns shown in Fig. 3 rule out that the nearly complete
loss of active force results from a massive structural disor-
der in the fibers incubated with Fab(I-7).
Inhibition of fiber stiffness by Fab(1-7) in rigor
and in the presence of MgPP1
Several measurements were carried out to test whether the
complete inhibition of active force by Fab, in contrast to a
smaller loss of relaxed fiber stiffness, was due to greater
inhibition of strong than of weak cross-bridge interactions
with actin. In these experiments, the effects of Fab(1-7) on
active force and fiber stiffness under relaxing and strong
binding (rigor or in the presence of 4 mM MgPPi) condi-
tions were compared. Fig. 4 shows that Fab(I-7) apparently
is able to inhibit fiber stiffness in rigor or in the presence of
MgPPi to a larger extent than in relaxed fibers (open col-
umns). In the presence of Fab, however, fiber stiffness in
rigor and in the presence of MgPPi was still higher than in
relaxed fibers under the same ionic conditions (shaded
columns). Thus, the difference in the inhibition of active
force versus relaxed fiber stiffness may be due in part to
additional interference of Fab(I-7) with the transition to
and/or with strong cross-bridge interactions.
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FIGURE 3 Equatorial diffraction patterns of re-
laxed fibers (,u = 50 mM) in the presence and ab-
sence of Fab(1-7). The fibers were incubated for 12 h
in relaxing solution (,SO0 mM) with 0.1 mg/ml Fab
before recording diffraction patterns in the presence
of Fab(1-7).
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FIGURE 4 Inhibition of relaxed fiber stiffness (,u = 50 mM), stiffness in
rigor (, = 170 mM), and stiffness in the presence of 4 mM MgPPi (,L =
170 mM). Stiffness values in the presence of Fab were normalized for each
condition to the stiffness in the absence of Fab(I-7) (open columns) or to
the rigor stiffness in presence of Fab (shaded columns). The concentration
of Fab was 0.05 mg/ml.
Effect of Ca2+ on the inhibition of cross-bridge
binding to actin by Fab(1-7)
Another possible reason for the much more effective inhi-
bition of active force compared with relaxed fiber stiffness
could be a more potent inhibition of weak cross-bridge
binding to actin by Fab(1-7) in the presence of Ca2 ,
similar to our observations with caldesmon and its actin-
binding fragments (Kraft et al., 1995a). To address this
possibility, under conditions at which active force was es-
sentially abolished, we examined 1) the inhibition of fiber
stiffness by Fab(I-7) in the presence of ATP and ATPyS at
high (pCa 4.5) and low Ca2+ (pCa > 8) and 2) the effect of
Ca2+ on fiber equatorial diffraction patterns. We used
ATPyS as a slowly hydrolyzed ATP-analog (Goody and
Eckstein, 1971; Bagshaw et al., 1973; Dantzig et al., 1988;
Kraft et al., 1992) that allows accumulation of cross-bridges
in weakly binding states even in the presence of Ca2+. Thus,
even if some active turnover were still possible in the
presence of the Fab, with ATP-yS both at high and low Ca2+
essentially all cross-bridges accumulate in weak binding
states. If the complete inhibition of active force by Fab
(1-7) were related to a greater Fab effect on weak cross-
bridge binding to actin in the presence of Ca2+ then 1) fiber
stiffness observed with ATP or ATP-yS should be much
smaller in the presence of Ca2+ than in its absence (relaxing
conditions), and 2) equatorial diffraction patterns recorded
under the same conditions should show much less cross-
bridge attachment in the presence of Ca2+.
Fig. 5 shows that fiber stiffness is not significantly more
inhibited at high Ca2+ than at low Ca2+ in either the
presence of MgATP or of MgATPyS. Also (not shown),
FIGURE 5 Effect of Ca21 on the inhibition of fiber stiffness by
Fab(l-7) in the presence of MgATP (1.0 mM) or MgATP'yS (10 mM) (cf.
Kraft et al., 1992). Speed of stretch was -104 (nmlhalf-sarcomere)s - 1.
Note that at this speed of stretch stiffness in the presence of Ca2 , on
average, is comparable with that at the low Ca2' concentration. The
Fab(I-7) concentration was 0.05 mg/ml.
Ca2+ has no detectable effect on equatorial x-ray diffraction
patterns of fibers incubated with Fab(1-7) at both 50 and
170 mM ionic strength. Thus, both fiber stiffness and equa-
torial diffraction patterns indicate that the inhibition of weak
cross-bridge binding to actin by Fab(I-7) is not signifi-
cantly changed by the presence of Ca2+.
Effect of Ca2+ on stiffness-speed profiles
recorded in the presence of MgATPyS or MgATP
We recently demonstrated (Kraft et al., 1992) that 1) Ca2+
has a characteristic effect on stiffness speed of stretch
profiles in the presence of ATP-yS and that 2) this effect was
apparent even when the [ATPyS] was raised to counter its
lower affinity for myosin in the presence of Ca2+. At high
Ca2+, the stiffness-speed profiles were shifted by almost
two orders of magnitude to slower stretch velocities. Be-
cause actin affinity of cross-bridges in the presence of
ATP,yS was affected by Ca2+ only marginally, our data
suggests that actin binding kinetics of ATP'yS cross-bridges
were slowed by -20- to 100-fold at high Ca2+ (Kraft et al.,
1992).
The more effective inhibition of active force generation
by Fab(1-7) compared with inhibition of weak cross-bridge
attachment to actin could be due to the interference of
Fab(1-7) with the Ca2+-activation of fibers. This raises the
question of whether the Ca2+-effect on actin binding kinet-
ics of ATPyS cross-bridges is also abolished when active
force is completely inhibited by Fab(1-7). As shown in Fig.
6 A, when force is fully inhibited by Fab(I-7), Ca2+ still has
a similar effect on the stiffness-speed relationship in the
presence of 10 mM MgATPyS, as observed by Kraft et al.
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o studied (Fig. 6, B and C). The characteristic effect of Ca21
7 upon stiffness-speed relationship recorded in the presence
of MgATPyS, both with and without the Fab fragment, can
also be detected in the presence of MgATP.
* Fig. 6 C also includes data on rigor fiber stiffness (in the
absence of nucleotide) under the same ionic strength con-
ditions (170 mM). The rigor stiffness is strongly inhibited
and sensitive to the speed of stretch applied to the fiber. This
contrasts with fiber stiffness measurements in the absence
of both nucleotide and Fab(1-7). Without the Fab-fragment,
3 7 rigor fiber stiffness is essentially independent of speed of
stretch, at least over the range of velocities shown in Fig. 6.
Additional studies, however, will be necessary to further
characterize this speed-sensitive rigor stiffness, e.g., for
comparison with other conditions like the moderately strong
cross-bridge binding in the presence of MgPPi.
Activation of the contractile system by strong
cross-bridge binding to actin
Because Fab(1-7) could completely abolish active force
while weak cross-bridge binding both at high and low Ca2+
is still possible, the Fab apparently does not selectively
4 interfere with cross-bridge attachment in the presence of
Ca2 . It is possible, however, that active force inhibition by
Fab reflects an inhibition/blocking of a kinetic step in the
cross-bridge cycle subsequent to weak cross-bridge binding
to actin such that active cross-bridge cycling is impaired. To
probe for such Fab effects, we examined whether active
force can be recovered upon activation of actin filaments by
0 strong cross-bridge attachment, e.g., by decreasing MgATP
0 0~ concentration in the fiber. Fig. 7 shows that in the presence
of 0.05 mg/ml Fab(I-7), reduction of MgATP-concentra-
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FIGURE 6 Effect of Fab(I-7) on stiffness-speed relationship in the
presence and absence of Ca2 (A) 10 mM MgATPyS and 0.05 mg/mi
Fab(1-7), ,u = 75 mM; *-Ca2+, 0 +Ca2+; (B) 1 mM MgATP, ,u = 50
mM; *-Ca2+, 0 Ca2+; (C) I mM MgATP, ,u = 170 mM; i -Ca2+, 0
+Ca2+. All data normalized to stiffness observed with the fastest stretches
in the presence of Ca2+ at ,u = 50 mM. The concentration of Fab in B and
C was 0.48 mg/ml. The higher Fab concentration was used to ensure that
active force was completely abolished. In the presence of both ATP'yS and
ATP, stiffness-speed relationships are similarly affected by Ca2 Presum-
ably, no strong interactions due to active cross-bridge cycling were present
even with MgATP (no active force generated at this Fab concentration).
Also, note the speed dependence of the much inhibited fiber stiffness in the
absence of nucleotide (0, in C).
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(1992) in the absence of the Fab. A similar behavior was
observed in the presence of MgATP, after the active force in
fibers was completely abolished with 0.48 mg/ml Fab(I-7),
i.e., under conditions at which possible Ca2+ effects on
weak interactions in the presence of MgATP could be
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FIGURE 7 Effect of a decrease in MgATP concentration on the inhib-
ited active force. Fab concentration was 0.05 mg/ml; = 170 mM. (At
higher Fab concentrations, active force did not recover, even at low ATP
concentrations; data not shown).
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tion allows active tension to recover to some degree. How-
ever, the extent of recovery seems to be limited to the level
at which fiber stiffness is inhibited by Fab(l-7) in the
presence of MgPPi or in rigor. At high concentrations of
Fab(1-7), e.g., 0.48 mg/ml, at which stiffness in rigor and in
the presence of MgPPi are much more inhibited (to -5% of
their initial stiffness in the absence of Fab), no recovery of
active force is seen with decreasing amounts of MgATP. In
this case there may be too few strong cross-bridge interac-
tions, even in the absence of nucleotide, to achieve signif-
icant activation of the thin filament.
DISCUSSION
The major findings of the present study are summarized
below.
Under conditions at which Fab(1-7) inhibits relaxed fiber
stiffness only partially, active force generation can be com-
pletely abolished. The active force cannot be recovered by
an increase in free [Ca2+]. Also, the inhibition of active
force larger than that of relaxed fiber stiffness cannot be
accounted for by a more effective inhibition of weak cross-
bridge binding to actin in the presence of Ca2+ (tested in the
presence of ATPyS as nucleotide analog), as was shown
previously in the case of caldesmon interference with weak
cross-bridge binding to actin (Kraft et al., 1995a). However,
some recovery of active force is achieved by decreasing
[MgATP], i.e., by activation of the contractile system
through strong cross-bridge binding.
Fiber stiffness in the absence of nucleotides (rigor) or in
the presence of MgPPi (i.e., when cross-bridges are strongly
bound to actin) is also inhibited, even to a larger proportion
than relaxed fiber stiffness. However, although more effec-
tively inhibited, stiffness observed in the absence of nucle-
otide or in the presence of MgPPi is still larger than the
relaxed fiber stiffness under similar ionic conditions. Upon
inhibition by Fab(1-7), rigor fiber stiffness seems more
sensitive to speed of stretch than it is in the absence of Fab.
Ca21 still affects weak cross-bridge binding to actin in
the presence of MgATPyS, even when active force is es-
sentially absent and weak interactions are partially inhibited
by Fab.
Inhibition of fiber stiffness in the absence of nucleotide
and in the presence of MgPPi is somewhat unexpected if the
N-terminus of actin, against which the Fab is targeted, is
involved only in weak cross-bridges binding to actin or
contributes little to actin affinity of the strongly bound
myosin. However, considering the size of a Fab molecule
and the flexibility of the N-terminus of actin, it would not be
surprising if some area on the surface of actin, in addition to
its N-terminus, is shielded from the interaction with myosin
heads. Such a shielding, although not apparent in a recent
electron microscopy study of actin-Fab(I-7) complexes
(Orlova et al., 1994), may strongly depend on the density of
actin decoration by Fab. That strong cross-bridge binding is
tence of ternary complexes of actin-Fab-S 1 in solution
(DasGupta and Reisler, 1991). The steric interference with
strong cross-bridge binding to actin, however, cannot ac-
count for the much more effective inhibition of active force.
The force is essentially abolished under conditions at which
fiber stiffness in the absence of nucleotide or with MgPPi is
still between 20 and 50% of its value in the absence of Fab.
One way to account for the much more effective inhibi-
tion of active force by Fab is to consider the antibody
binding to the N-terminus of actin as analogous to the
interaction of TnI with the N-terminus of actin in the ab-
sence of Ca2+. The TnI binding to actin in conjunction with
changes in tropomyosin results in the inhibition of active
cross-bridge cycling within a regulated unit of actin, but not
only at that actin monomer to which the TnI molecule is
bound. However, although TnI dissociates from the N-
terminus of actin upon Ca2+-binding to TnC, the Fab is not
expected to do so. Thus, the bound Fab may interfere with
the activation of the regulated actin unit when Ca21 con-
centration is raised. Such a possibility has been indicated by
solution studies with actin, S-1, and Fab(I-7) (DasGupta
and Reisler, 1991). Accordingly, partial occupancy of actin
filaments by Fab(1-7) may result in a complete inhibition of
activation (i.e., active force generation) and only partial
inhibition of relaxed and rigor fiber stiffness.
At the molecular level, complete inhibition of active
force and the more effective inhibition of strong cross-
bridge binding compared with weak binding could be ac-
counted for if Fab(1-7) interferes with the movement of
tropomyosin to its activated state on actin, i.e., the state that
allows strong cross-bridge interaction with actin. This view
is supported by the observation that Fab(l-7) alters cross-
bridge binding to actin in the absence of nucleotide, as
indicated by changes in the fiber stiffness speed relation-
ship. In the absence of Fab(1-7), rigor fiber stiffness is little
dependent on the speed of stretch (Brenner et al., 1986). At
high [Fab(1-7)], however, the stiffness speed relationship is
rather similar to that of weakly bound cross-bridges (Fig. 7
C), as if more rigid bonds were blocked. Most likely, the
effect of Fab(l-7) on tropomyosin is indirect, via TnI.
Fab(1-7) should alter the interactions of TnI with actin
(because of the competition for the N-terminus of actin;
DasGupta and Reisler, unpublished data) and perhaps with
other Tn subunits and with tropomyosin. Such altered sub-
unit interactions within the regulatory complex could impair
tropomyosin movement on actin.
The detectable effect of Ca2+ on weak cross-bridge in-
teractions with actin in the presence of Fab(l-7) may seem
somewhat surprising in the context of the above explana-
tion. However, Fab(l-7) may interfere only with more
extended tropomyosin movements such that active cross-
bridge cycling and strong cross-bridge binding are affected,
whereas more subtle Ca2+ effects on weakly bound cross-
bridges may still be possible (Fig. 6).
Another molecular scenario, which could explain both
the strong inhibition of active force and the inhibition of
strong cross-bridge binding to actin by Fab(l-7), is that the
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not completely blocked has been demonstrated by the exis-
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antibody inhibits or blocks a kinetic step after the weak
binding of cross-bridges to actin. Clearly, if a transition
from weakly to strongly bound states of actomyosin is
blocked, no active force would be developed. However,
even rigor stiffness would be strongly inhibited in such a
case because all fiber incubations with Fab(l-7) were car-
ried out under relaxing conditions. Thus, the subsequent
transfer of these fibers to a rigor solvent may not eliminate
completely the inhibition of the transition between weakly
and strongly bound cross-bridge states. It is not difficult to
provide a structural rationale for such a molecular explana-
tion of Fab action. The binding of the N-terminus of actin to
the 626-647 loop on myosin may provide an appropriate
"ordering template" for this random coil segment of S-1.
The disorder-order transition of this loop (cf. Holmes,
1995), which is strategically positioned over strongly bind-
ing segments of actin, could increase the stereospecificity of
the weak cross-bridge binding to actin and thus facilitate
formation of stereospecific, strong actomyosin binding and
a shift from less ordered (nonstereospecific) to ordered
(stereospecific) cross-bridge attachment (Matsuda and
Podolsky, 1984; Craig et al., 1985; Applegate and Flicker,
1987; Yu and Brenner, 1989; Brenner and Yu, 1993a;
Berger and Thomas, 1994; Walker et al., 1994, 1995; Bren-
ner et al., 1995; Thomas et al., 1995). The binding of
Fab(1-7) to the N-terminus of actin would then interfere
with such ordering of the 626-647 loop on SI and the
transition to the strongly bound cross-bridge states. This
explanation could also account for the loss of in vitro
motility and actomyosin ATPase activity in N-terminal ac-
tin mutants (Sutoh et al., 1991; Cook et al., 1993). These
ideas could be tested and additional insight into the mech-
anisms by which Fab and perhaps actin mutants interfere
with the activation of the thin filaments could be gained
from studies using fluorescently labeled regulatory proteins
incorporated into the skinned fibers.
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